{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:32:44Z","timestamp":1779114764308,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,7,27]],"date-time":"2016-07-27T00:00:00Z","timestamp":1469577600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Telethon New Children\u2019s Hospital Research Fund","award":["F55541"],"award-info":[{"award-number":["F55541"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s13346-016-0313-z","type":"journal-article","created":{"date-parts":[[2016,7,27]],"date-time":"2016-07-27T14:45:25Z","timestamp":1469630725000},"page":"572-578","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Preliminary consultation on preferred product characteristics of benzathine penicillin G for secondary prophylaxis of rheumatic fever"],"prefix":"10.1007","volume":"6","author":[{"given":"Rosemary","family":"Wyber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben J","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Colquhoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart J","family":"Currie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Engel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Kado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesan","family":"Karthikeyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meru","family":"Sheel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Steer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Mucumbitsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liesl","family":"Z\u00fchlke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Carapetis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,27]]},"reference":[{"key":"313_CR1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","volume":"5","author":"J Carapetis","year":"2005","unstructured":"Carapetis J, Steer A, Mulholland E, Weber M. The global burden of group A streptococcal disease. Lancet Infect Dis. 2005;5:685\u201394.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"313_CR2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.gheart.2013.08.008","volume":"8","author":"L Zuhlke","year":"2013","unstructured":"Zuhlke L, Steer A. Estimates of the global burden of rheumatic heart disease. Global Heart. 2013;8(3):189\u201395.","journal-title":"Global Heart"},{"key":"313_CR3","volume-title":"Rheumatic fever and rheumatic heart disease","author":"WHO","year":"2001","unstructured":"WHO. Rheumatic fever and rheumatic heart disease. Geneva: World Health Organization; 2001."},{"key":"313_CR4","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/hrt.2004.042762","volume":"91","author":"Z Meira","year":"2005","unstructured":"Meira Z, Goulart E, Colosimo E, Mota C. Long term follow up of rheumatic fever and predictors of severe rheumatic valvular disease in Brazilian children and adolescents. Heart. 2005;91:1019\u201302.","journal-title":"Heart"},{"key":"313_CR5","unstructured":"WHO. Rheumatic fever and rheumatic heart disease. Report of a WHO Expert Consultation. Geveva, 29 October - 1 November 2001. Geneva: World Health Organization. WHO Technical Report Series 9232004."},{"issue":"19","key":"313_CR6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJM195505122521901","volume":"252","author":"G Stollerman","year":"1955","unstructured":"Stollerman G, Rusoff J, Hirschfeld I. Prophylaxis against group A Streptocci in rheumatic fever. The use of single monthly injections of benzathine penicillin G. N Engl J Med. 1955;252(19):787\u201392.","journal-title":"N Engl J Med"},{"key":"313_CR7","volume-title":"Penicillin for secondary prevention of rheumatic fever: Cochrane collaboration","author":"J Manyemba","year":"2009","unstructured":"Manyemba J, Mayosi B. Penicillin for secondary prevention of rheumatic fever: Cochrane collaboration. 2009."},{"key":"313_CR8","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1136\/heartjnl-2013-303896","volume":"99","author":"L Z\u00fchlke","year":"2013","unstructured":"Z\u00fchlke L, Mirabel M, Marijon E. Congenital heart disease and rheumatic heart disease in Africa: recent advances and current priorities. Heart. 2013;99:1554\u201361.","journal-title":"Heart"},{"key":"313_CR9","volume-title":"WHO Model List of Essential Medicines","author":"WHO","year":"2011","unstructured":"WHO. WHO Model List of Essential Medicines. 17th ed. Geneva: World Health Organization; 2011.","edition":"17"},{"issue":"4","key":"313_CR10","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1177\/2150135113497240","volume":"4","author":"N Wilson","year":"2013","unstructured":"Wilson N. Secondary prophylaxis for rheumatic fever: simple concepts, difficult delivery. World J Pediatr Congenit Heart Surg. 2013;4(4):380\u20134.","journal-title":"World J Pediatr Congenit Heart Surg"},{"issue":"1243","key":"313_CR11","first-page":"U2255","volume":"119","author":"S Grayson","year":"2006","unstructured":"Grayson S, Horsburgh M, Lennon D. An Auckland regional audit of the nurse-led rheumatic fever secondary prophylaxis programme. N Z Med J. 2006;119(1243):U2255.","journal-title":"N Z Med J"},{"issue":"1329","key":"313_CR12","first-page":"26","volume":"124","author":"S Viali","year":"2011","unstructured":"Viali S, Saena P, Futi V. Rheumatic fever program in Samoa. N Z Med J. 2011;124(1329):26\u201335.","journal-title":"N Z Med J"},{"issue":"4","key":"313_CR13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1445-5994.2012.02838.x","volume":"43","author":"M Remond","year":"2013","unstructured":"Remond M, Severin K, Hodder Y, Martin J, Nelson C, Atkinson D, et al. Variability in disease burden and management of rheumatic fever and rheumatic heart disease in two regions of tropical Australia. Intern Med J. 2013;43(4):386\u201393.","journal-title":"Intern Med J"},{"key":"313_CR14","doi-asserted-by":"publisher","unstructured":"Gasse B, Barous N, Rouchon B, Meunier J, De Fremicourt I, D\u2019Ortenzio E. Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledoina: a retrospective cohort study. BMC Public Health. 2013;13:131. doi: 10.1186\/471-2458-13-131 .","DOI":"10.1186\/471-2458-13-131"},{"key":"313_CR15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1546-0096-8-22","volume":"8","author":"C Pelajo","year":"2010","unstructured":"Pelajo C, Lopez-Benitez J, Torres J, de Oliveria S. Adherence to secondary prophylaxis and disease recurrence in 536 Brazilian children with rheumatic fever. Pediatr Rheumatol. 2010;8:22.","journal-title":"Pediatr Rheumatol"},{"key":"313_CR16","unstructured":"Carapetis J. Improving delivery of secondary prophylaxis for rheumatic heart disease. Australian New Zealand Clinical Trials Registry, Trial ID ACTRN12613000223730. 2013. https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=363642 . Accessed 7 Oct 2013."},{"issue":"1","key":"313_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13063-016-1166-y","volume":"17","author":"AP Ralph","year":"2016","unstructured":"Ralph AP, Read C, Johnston V, de Dassel JL, Bycroft K, Mitchell A, et al. Improving delivery of secondary prophylaxis for rheumatic heart disease in remote Indigenous communities: study protocol for a stepped-wedge randomised trial. Trials. 2016;17(1):51. doi: 10.1186\/s13063-016-1166-y .","journal-title":"Trials"},{"issue":"1","key":"313_CR18","first-page":"12","volume":"2","author":"P Burton","year":"1999","unstructured":"Burton P. Regarding compliance with medications and in particular compliance among Aboriginal Australians. Letter to the editor from an AMS doctor. NACCHO News National Aboriginal Community Controlled Health Organisation. 1999;2(1):12\u20134.","journal-title":"NACCHO News National Aboriginal Community Controlled Health Organisation"},{"issue":"1","key":"313_CR19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/0974-2069.79616","volume":"4","author":"J Carapetis","year":"2011","unstructured":"Carapetis J, Zuhlke L. Global research priorities in rheumatic fever and rheumatic heart disease. Ann Pediatr Cardiol. 2011;4(1):4\u201312.","journal-title":"Ann Pediatr Cardiol"},{"issue":"3","key":"313_CR20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.gheart.2013.08.011","volume":"8","author":"R Wyber","year":"2013","unstructured":"Wyber R, Taubert K, Marko S, Kaplan E. Benzathine penicillin G for the management of RHD: concerns about quality and access, and opportunities for intervention and improvement. Global Heart. 2013;8(3):227\u201334.","journal-title":"Global Heart"},{"key":"313_CR21","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/INF.0b013e318259b75c","volume":"317","author":"E Kaplan","year":"2012","unstructured":"Kaplan E. Benzathine Penicillin G: a documentably important antibiotic in need of a tune up? Pediatr Infect Dis J. 2012;317:726\u20138.","journal-title":"Pediatr Infect Dis J"},{"key":"313_CR22","unstructured":"Malik K. Human Development Report 2013, The Rise of the South: Human Progress in a Diverse World: United Nations Development Programme 2013. Report No.: 978-92-1-126340-4."},{"key":"313_CR23","unstructured":"WHO. WHO Preferred Product Characteristics. World Health Organizaation. 2015. http:\/\/www.who.int\/immunization\/research\/vaccine_preferred_product_characteristics\/en\/ . Accessed 10 July 2015."},{"key":"313_CR24","volume-title":"Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease","author":"RHDAustralia","year":"2012","unstructured":"RHDAustralia. Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease. 2nd ed. New Zealand: National Heart Foundation of Australia and Cardiac Society of Australia; 2012.","edition":"2"},{"key":"313_CR25","volume-title":"Tools for Implementing RHD Control Programmes (TIPS) Handbook","author":"R Wyber","year":"2014","unstructured":"Wyber R, Grainger Gasser A, Thompson D, Kennedy D, Johnson T, Taubert K, et al. Tools for Implementing RHD Control Programmes (TIPS) Handbook. Perth: World Heart Federation and RhEACH; 2014."},{"issue":"2","key":"313_CR26","first-page":"140","volume":"3","author":"M Tullu","year":"2010","unstructured":"Tullu M, Ghandi A, Ghildiyal R. Benzathine penicillin prophylaxis in children with rheumatic fever\/rheumatic heart disease: a study of compliance. Al Ameen J Med Sci. 2010;3(2):140\u20135.","journal-title":"Al Ameen J Med Sci"},{"key":"313_CR27","doi-asserted-by":"crossref","first-page":"514","DOI":"10.5694\/j.1326-5377.2006.tb00347.x","volume":"184","author":"Z Harrington","year":"2006","unstructured":"Harrington Z, Thomas D, Currie B, Bulkanhawuy J. Challenging perceptions of non-compliance with rheumatic fever prophylaxis in a remote Aboriginal community. Med J Aust. 2006;184:514\u20137.","journal-title":"Med J Aust"},{"issue":"4","key":"313_CR28","doi-asserted-by":"crossref","first-page":"124","DOI":"10.5830\/CVJA-2013-022","volume":"24","author":"C Musoke","year":"2013","unstructured":"Musoke C, Mondo C, Okello E, Zhang W, Kakande B, Nyakoojo W, et al. Benzathine penicillin adherence for secondary prophylaxis among heart patients affected with rheumatic heart disease attending Mulago Hospital. Cardiovasc J Afr. 2013;24(4):124\u20139.","journal-title":"Cardiovasc J Afr"},{"issue":"5","key":"313_CR29","first-page":"781","volume":"72","author":"K Walker","year":"1987","unstructured":"Walker K, Human D, de Moor M, Sprenger K. The problem of compliance in rheumatic fever. S Afr Med J. 1987;72(5):781\u20133.","journal-title":"S Afr Med J"},{"key":"313_CR30","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1542\/peds.97.6.989","volume":"97","author":"B Currie","year":"1996","unstructured":"Currie B. Are the currently recommended doses of benzathine penicillin G adequate for secondary prophylaxis of rheumatic fever. Pediatrics. 1996;97:989\u201391.","journal-title":"Pediatrics"},{"issue":"1","key":"313_CR31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/2395-5414.157554","volume":"1","author":"R Wyber","year":"2015","unstructured":"Wyber R, Carapetis J. Evolution, evidence and effect of secondary prophylaxis against rheumatic fever. J Pract Cardiovasc Sci. 2015;1(1):9\u201314.","journal-title":"J Pract Cardiovasc Sci"},{"issue":"1","key":"313_CR32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.gheart.2014.10.001","volume":"10","author":"D Huck","year":"2015","unstructured":"Huck D, Nalubwama H, Longenecker C, Frank S, Okello E, Webel A. A qualitative examination of secondary prophylaxis in rheumatic heart disease. Global Heart. 2015;10(1):63\u20139.","journal-title":"Global Heart"},{"issue":"2","key":"313_CR33","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/jpc.12400","volume":"50","author":"K Russell","year":"2013","unstructured":"Russell K, Nicholson R, Naidu R. Reducing the pain of intramuscular benzathine penicillin injections in the rheumatic fever population of Counties Manukau District Health Board. J Paediatr Child Health. 2013;50(2):112\u20137.","journal-title":"J Paediatr Child Health"},{"issue":"9960","key":"313_CR34","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/S0140-6736(14)60841-2","volume":"384","author":"A Bowen","year":"2014","unstructured":"Bowen A, Tong S, Andrews R. Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled non-inferiority trial. Lancet. 2014;384(9960):2132\u201340.","journal-title":"Lancet"},{"issue":"5","key":"313_CR35","first-page":"236","volume":"6","author":"M Morsy","year":"2012","unstructured":"Morsy M, Mohamed M, Abosedira M, Al-Harbi K, Abdelazia N, Hal S, et al. Lidocaine as a diluent for benzathine penicillin G reduces injection pain in patients with rheumatic fever: a prospective, randomized, double-blinded crossover study. Aust J Basic Appl Sci. 2012;6(5):236\u201340.","journal-title":"Aust J Basic Appl Sci"},{"key":"313_CR36","unstructured":"Saxena A. Personal correspondence to Wyber R. Cost of rheumatic heart disease therapy. 2014."},{"issue":"1S","key":"313_CR37","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/j.gheart.2014.03.1325","volume":"9","author":"R Heenan","year":"2014","unstructured":"Heenan R, Bargnighausen T, O\u2019Brien J, Parks T, Kado J, Bloom D, et al. The cost-of-illness of rheumatic heart disease: a national estimation in Fiji. Global Heart. 2014;9(1S):e30.","journal-title":"Global Heart"},{"key":"313_CR38","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrcardio.2013.34","volume":"10","author":"B Remenyi","year":"2013","unstructured":"Remenyi B, Carapetis J, Wyber R, Taubert K, Mayois B. Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease. Nat Rev Cardiol. 2013;10:284\u201392.","journal-title":"Nat Rev Cardiol"},{"issue":"9259","key":"313_CR39","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S0140-6736(00)04203-3","volume":"357","author":"K Morris","year":"2001","unstructured":"Morris K. Growing pains of East Timor: health of an infant nation. Lancet. 2001;357(9259):873\u20137. doi: 10.1016\/S0140-6736(00)04203-3 .","journal-title":"Lancet"},{"key":"313_CR40","volume-title":"World Health Organization","author":"World Atlas of Ageing","year":"1998","unstructured":"World Atlas of Ageing. World Health Organization. 1998. Contract No.: WHO\/WCK\/TECH\/SER\/98.1."},{"key":"313_CR41","volume-title":"Guidance for industry and review staff. Target product profile\u2014a strategic development process tool","author":"FDA","year":"2007","unstructured":"FDA. Guidance for industry and review staff. Target product profile\u2014a strategic development process tool. Rockville: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER); 2007. Contract No.: I:\\6910dft.doc."},{"issue":"1","key":"313_CR42","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/clpt.2009.71","volume":"86","author":"B Poland","year":"2009","unstructured":"Poland B, Hodge F, Khan A, Clemen R, Wagner J, Dykstra K, et al. The clinical utility index as a practical multiattribute approach to drug development decisions. Clin Pharmacol Ther. 2009;86(1):105\u20138.","journal-title":"Clin Pharmacol Ther"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-016-0313-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13346-016-0313-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-016-0313-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T23:43:37Z","timestamp":1656891817000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13346-016-0313-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,27]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["313"],"URL":"https:\/\/doi.org\/10.1007\/s13346-016-0313-z","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,27]]}}}